Latest Breaking News On - Ursula geller professor of research - Page 1 : comparemela.com

Pitavastatin lowers plaque volume, progression in lower-risk patients with HIV

Pitavastatin lowers plaque volume, progression in lower-risk patients with HIV
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesHarvard universityRichard smithMichaelt luStevenk grinspoonPamelas douglasHeatherj ribaudoByerik swainUrsula geller professor of researchHarvard medical schoolDuke universityAmerican heart association scientific sessionsCardiovascular imaging research centerMassachusetts general hospitalAmerican heart association scientificPublic health

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United statesHarvard universityGaryh gibbonsHeather ribaudoPamela douglasMichaelt luHugh auchinclossSteven grinspoonGilead sciences incDuke university department of medicineNeat id foundationA national institutes of healthBlood instituteNational institute of allergyUrsula geller professor of researchNational heart

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from theA National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from the » The FINANCIAL Health&Beauty

United statesHarvard universityHeather ribaudoSteven grinspoonPamela douglasGaryh gibbonsHugh auchinclossMichaelt luClinical coordinating centerKowa pharmaceuticals america incBlood instituteGilead sciences incUrsula geller professor of researchData coordinating centerDuke university department of medicineHospital cardiovascular imaging research center

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

United statesHarvard universityPamela douglasMichaelt luSteven grinspoonEmily hendersonHeather ribaudoGaryh gibbonsHugh auchinclossDepartment of biostatistics at harvard universityNeat id foundationData coordinating centerClinical trials groupNational heartA national institutes of healthKowa pharmaceuticals america inc

Precision testing strategy strongly benefits stable patients with suspected CAD

CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% reduction in death, MI or catheterization without obstructive CAD at 1 year compared with the usual testing, researchers reported.For the PRECISE trial, presented at the American Heart Association Scientific Sessions, Pamela S. Douglas, MD, MACC, FASE, FAHA, Ursula Geller Professor

United statesJulia indikPamelas douglasAmerican heart associationAmerican college of cardiologyCardiovascular diseases at duke universityAmerican heart association scientific sessionsHeart disease researchUrsula geller professor of researchUniversity of arizona college medicineFlinn foundationUrsula geller professorCardiovascular diseasesDuke universityAmerican collegeRisk score